Prenetics Global Limited(PRE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -4.17 | Insider Own | 22.64% | Shs Outstand | 15.2M | Perf Week | -1.07% |
| Market Cap | 0.31B | Forward P/E | - | EPS next Y | 49.79% | Insider Trans | 1.26% | Shs Float | 13.1M | Perf Month | -19.02% |
| Enterprise Value | 0.20B | PEG | - | EPS next Q | -0.82 | Inst Own | 7.15% | Short Float | 3.93% | Perf Quarter | 2.28% |
| Income | -0.07B | P/S | 2.19 | EPS this Y | 7.33% | Inst Trans | -16.78% | Short Ratio | 2.49 | Perf Half Y | 0.27% |
| Sales | 0.14B | P/B | 3.32 | EPS next 5Y | 54.25% | ROA | -39.86% | Short Interest | 0.51M | Perf YTD | 17.02% |
| Book/sh | 5.56 | P/C | 2.85 | EPS past 3/5Y | 58.51% 34.71% | ROE | -57.62% | 52W High | -32.34% ($27.24) | Perf Year | 40.9% |
| Cash/sh | 6.46 | P/FCF | - | Sales past 3/5Y | 91.46% -23.93% | ROIC | -72.58% | 52W Low | 62.16% ($11.36) | Perf 3Y | 228.87% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -5.43% | Gross Margin | 63.22% | Volatility(W/M) | 8.63% 7.54% | Perf 5Y | -83.96% |
| Dividend TTM | - | EV/Sales | 1.43 | Sales Y/Y TTM | 182.05% | Oper. Margin | -35.48% | ATR (14) | 1.5 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.66 | EPS Q/Q | 49.36% | Profit Margin | -47.43% | RSI (14) | 40.51 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.04 | Sales Q/Q | 210.67% | SMA20 | -7.81% ($19.99) | Beta | 0.37 | Target Price | $40.56 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/8/18 | SMA50 | -16.55% ($22.09) | Rel Volume | 1.21 | Prev Close | $18.37 |
| Employees | 98 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 36.9% -6.74% | SMA200 | -5.74% ($19.55) | Avg Volume(3M) | 0.21M | Price | $18.43 |
| IPO | 2021/7/16 | Option/Short | Yes/Yes | Trades | 1705 | Volume | 249,510 | Change | 0.33% |
🧬 A global health sciences company focused on consumer health and wellness along with genetic testing. It operates the health and wellness brand iMe8, the sports nutrition distribution brand Europa, and the next-generation sequencing–based consumer genetic testing brand CircleDNA, with a focus on the direct-to-consumer health market.
Over the past 1 year, roughly in the middle
32% below its 1-year high.
Traded about as much as usual. That is 121% of its average volume.
PRE has a sound balance sheet but weak earning power
Of every $100 in sales, $35.48 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +7.3% this year.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $219. Peers typically go for $70.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -84.0%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 7.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
BCOR Grayscale Bitcoin Adopters ETF <0.01% 
IWC iShares Micro-Cap ETF <0.01% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
IAU iShares Gold Trust 59.9B 
PFF iShares Trust iShares Preferred and Income Securities ETF 11.8B 
BLCR iShares Large Cap Core Active ETF 9.7B 
SGOL Abrdn Gold ETF Trust 6.9B 
FPE First Trust Preferred Securities and Income ETF 5.8B It ranks #35 of 61 in the industry
Based on market cap of $312M.
OTLY#33 Oatly Group AB ADR $375M PER - 
LWAY#34 Lifeway Foods Inc $351M PER 33.1 PRE#35 Prenetics Global Limited $312M PER - 
BRCC#36 BRC Inc $290M PER - 
USNA#37 Usana Health Sciences Inc $260M PER - 
FAQ
What kind of company is PRE?
PRE belongs to the Consumer Defensive sector and operates in the Packaged Foods industry.
What is the market cap of PRE?
The market cap of PRE is approximately $312M, ranking 3,602 within its sector.
What is the 52-week high and low for PRE?
PRE has recorded a 52-week high of $27.24 and a low of $11.36.
